- Home
- IREN vs AMPH Comparison
IREN vs AMPH Comparison
Compare IREN & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IREN
- AMPH
- Stock Information
- Founded
- IREN 2018
- AMPH 1996
- Country
- IREN Australia
- AMPH United States
- Employees
- IREN N/A
- AMPH N/A
- Industry
- IREN EDP Services
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- IREN Technology
- AMPH Health Care
- Exchange
- IREN Nasdaq
- AMPH Nasdaq
- Market Cap
- IREN 1.4B
- AMPH 1.3B
- IPO Year
- IREN 2021
- AMPH 2014
- Fundamental
- Price
- IREN $5.59
- AMPH $23.35
- Analyst Decision
- IREN Strong Buy
- AMPH Hold
- Analyst Count
- IREN 11
- AMPH 3
- Target Price
- IREN $19.30
- AMPH $43.50
- AVG Volume (30 Days)
- IREN 13.6M
- AMPH 745.5K
- Earning Date
- IREN 05-14-2025
- AMPH 05-07-2025
- Dividend Yield
- IREN N/A
- AMPH N/A
- EPS Growth
- IREN N/A
- AMPH 17.69
- EPS
- IREN N/A
- AMPH 3.06
- Revenue
- IREN $285,765,000.00
- AMPH $731,967,000.00
- Revenue This Year
- IREN $183.61
- AMPH $2.15
- Revenue Next Year
- IREN $80.31
- AMPH $6.64
- P/E Ratio
- IREN N/A
- AMPH $7.63
- Revenue Growth
- IREN 133.25
- AMPH 13.59
- 52 Week Low
- IREN $4.15
- AMPH $22.74
- 52 Week High
- IREN $15.92
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- IREN 38.67
- AMPH 32.78
- Support Level
- IREN $5.24
- AMPH $22.64
- Resistance Level
- IREN $5.93
- AMPH $24.92
- Average True Range (ATR)
- IREN 0.60
- AMPH 1.29
- MACD
- IREN 0.07
- AMPH -0.22
- Stochastic Oscillator
- IREN 28.10
- AMPH 10.71
About IREN Iris Energy Limited
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.